A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension

Summary

The purpose of this trial is to investigate safety, tolerability, pharmacodynamics (PD), and pharmacokinetics (PK) after intravenous (IV) administration of FE 204205 in patients with cirrhotic portal hypertension.

Timeline

Start

2016-11

Primary completion

2017-09-27

Completion

2017-09-27

Outcome

Outcome not reported

Stopped (Enrollment): “Trial terminated due to difficult recruitment”

Drugs

Indications